E. Rüther

1.3k total citations
21 papers, 407 citations indexed

About

E. Rüther is a scholar working on Psychiatry and Mental health, Physiology and Epidemiology. According to data from OpenAlex, E. Rüther has authored 21 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in E. Rüther's work include Schizophrenia research and treatment (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Electroconvulsive Therapy Studies (3 papers). E. Rüther is often cited by papers focused on Schizophrenia research and treatment (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Electroconvulsive Therapy Studies (3 papers). E. Rüther collaborates with scholars based in Germany and Austria. E. Rüther's co-authors include Jens Wiltfang, Johannes Kornhuber, Markus Otto, Gerald Huether, Erik Bahn, M. Bagli, R. Grohmann, Aribert Rothenberger, Gunther H. Moll and W. Nolte and has published in prestigious journals such as Journal of Neurochemistry, Electrophoresis and Neuropsychobiology.

In The Last Decade

E. Rüther

20 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Rüther Germany 11 133 132 66 54 49 21 407
Parviz Malek-Ahmadi United States 10 109 0.8× 35 0.3× 17 0.3× 49 0.9× 37 0.8× 32 285
C L Raison United States 3 143 1.1× 57 0.4× 42 0.6× 48 0.9× 29 0.6× 3 677
Guoqing Zhao China 12 120 0.9× 93 0.7× 39 0.6× 51 0.9× 41 0.8× 30 478
Patricia Huezo-Diaz Switzerland 12 47 0.4× 75 0.6× 23 0.3× 49 0.9× 32 0.7× 21 475
F. Gambi Italy 11 130 1.0× 42 0.3× 41 0.6× 28 0.5× 26 0.5× 20 339
A. Zanoboni Italy 11 73 0.5× 38 0.3× 103 1.6× 21 0.4× 47 1.0× 24 421
E. Garelis Canada 9 158 1.2× 84 0.6× 63 1.0× 57 1.1× 232 4.7× 16 454
Andrew F. Pitts United States 11 25 0.2× 72 0.5× 39 0.6× 27 0.5× 130 2.7× 16 463
Susumu Fukui Japan 11 52 0.4× 96 0.7× 32 0.5× 57 1.1× 149 3.0× 27 347
Barent DuBois United States 10 133 1.0× 74 0.6× 79 1.2× 32 0.6× 93 1.9× 21 474

Countries citing papers authored by E. Rüther

Since Specialization
Citations

This map shows the geographic impact of E. Rüther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Rüther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Rüther more than expected).

Fields of papers citing papers by E. Rüther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Rüther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Rüther. The network helps show where E. Rüther may publish in the future.

Co-authorship network of co-authors of E. Rüther

This figure shows the co-authorship network connecting the top 25 collaborators of E. Rüther. A scholar is included among the top collaborators of E. Rüther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Rüther. E. Rüther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoppe, Gabriela, Hagen Sandholzer, J. Staedt, et al.. (2008). Einflußfaktoren auf die Verordnung von Nootropika*: Ergebnisse einer repräsentativen Umfrage in Niedersachsen. DMW - Deutsche Medizinische Wochenschrift. 120(47). 1614–1619.
2.
Lewczuk, Piotr, Hermann Esselmann, Mirko Bibl, et al.. (2004). Electrophoretic separation of amyloid β peptides in plasma. Electrophoresis. 25(20). 3336–3343. 48 indexed citations
4.
Sommer, Martin, et al.. (2001). Subclinical Pancreatitis Related to Mirtazapine - A Case Report. Pharmacopsychiatry. 34(4). 158–159. 4 indexed citations
5.
Gil, Francisco Pedrosa, R. Grohmann, & E. Rüther. (2001). Asymptomatic Bradycardia Associated with Amisulpride. Pharmacopsychiatry. 34(6). 259–261. 10 indexed citations
6.
Grohmann, R., et al.. (1999). Two Cases of Olanzapine-lnduced Reversible Neutropenia. Pharmacopsychiatry. 32(4). 154–156. 23 indexed citations
7.
Wiltfang, Jens, W. Nolte, Markus Otto, et al.. (1999). Elevated Serum Levels of Astroglial S100β in Patients with Liver Cirrhosis Indicate Early and Subclinical Portal-Systemic Encephalopathy. Metabolic Brain Disease. 14(4). 239–251. 23 indexed citations
8.
Wiltfang, Jens, Markus Otto, Helen C. Baxter, et al.. (1999). Isoform Pattern of 14‐3‐3 Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt‐Jakob Disease. Journal of Neurochemistry. 73(6). 2485–2490. 88 indexed citations
9.
Moll, Gunther H., et al.. (1999). Persistently Increased Density of Serotonin Transporters in the Frontal Cortex of Rats Treated with Fluoxetine During Early Juvenile Life. Journal of Child and Adolescent Psychopharmacology. 9(1). 13–24. 65 indexed citations
10.
Wiltfang, Jens, W. Nolte, Karin Weißenborn, Johannes Kornhuber, & E. Rüther. (1998). Psychiatric Aspects of Portal-Systemic Encephalopathy. Metabolic Brain Disease. 13(4). 379–389. 24 indexed citations
11.
Huether, Gerald, Sabine Schmidt, & E. Rüther. (1998). Nutritional Effects on Central Serotonergic Activity: A Hypothesis on the Unconscious Self-manipulation of Mood by Food Intake and Dietary Selection. Nutritional Neuroscience. 1(1). 3–7. 5 indexed citations
12.
Saletu, B., et al.. (1992). Therapeutic Efficacy of Pyritinol in Patients with Senile Dementia of the Alzheimer Type (SDAT) and Multi-infarct Dementia (MID). Neuropsychobiology. 26(1-2). 65–70. 33 indexed citations
13.
Wolf, Barbara C., et al.. (1989). A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use.. PubMed. 50(3). 99–100. 6 indexed citations
14.
Grohmann, R., et al.. (1988). Severe and Life-Threatening Adverse Reactions to Psychotropic Drugs. Pharmacopsychiatry. 21(6). 290–292. 3 indexed citations
15.
Grohmann, R., et al.. (1988). [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].. PubMed. 59(2). 118–23. 4 indexed citations
16.
Nedopil, Norbert, et al.. (1983). The Prediction of Acute Response, Remission and General Outcome of Neuroleptic Treatment in Acute Schizophrenic Patients*. Pharmacopsychiatry. 16(6). 201–205. 23 indexed citations
17.
Rüther, E., et al.. (1981). Initial Improvement as Predictor of Outcome of Neuroleptic Treatment*. Pharmacopsychiatry. 14(6). 205–207. 17 indexed citations
18.
Meier‐Ewert, K., et al.. (1975). [Three narcoleptic syndromes. Catamnestic and polygraphic results].. PubMed. 46(11). 624–35. 5 indexed citations
19.
Rüther, E., et al.. (1958). [The role of Candida mycoses (moniliasis) in gynecology and obstetrics].. PubMed. 18(1). 22–35. 8 indexed citations
20.
Rüther, E.. (1953). [Spontaneous fractures of femur neck and pubic bone after radiotherapy of malignant gynecological diseases].. PubMed. 13(7). 624–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026